Ceres Power Holdings plc Q&A with Zeus Capital (LON:CWR)
22 March 2018
HealthStream, Inc. (NASDAQ: HSTM), a prominent player in the healthcare information services sector, presents an intriguing opportunity for investors seeking growth in the healthcare technology space. As a Software-as-a-Service (SaaS)..
Investors with an eye on the biotechnology sector may find Precigen, Inc. (NASDAQ: PGEN) an intriguing prospect, given its focus on innovative gene and cell therapies. With a robust market..
Investors with a keen interest in the biotechnology sector should take note of Mind Medicine (MindMed) Inc. (MNMD), a company positioned at the forefront of developing innovative treatments for brain..
ArriVent BioPharma, Inc. (NASDAQ: AVBP) has recently caught the attention of investors with its promising pipeline in the biotechnology sector. As a clinical-stage biopharmaceutical company, ArriVent is dedicated to developing..
Beta Bionics, Inc. (BBNX), a prominent player in the healthcare sector, is emerging as a formidable force in the medical device industry. With a current market capitalization of $596.53 million,..
SIGA Technologies Inc. (NASDAQ: SIGA) might not be a household name in the vast landscape of healthcare, but this commercial-stage pharmaceutical company is making significant strides in the health security..
Investors seeking opportunities in the healthcare sector may want to turn their attention to Evolus, Inc. (NASDAQ: EOLS), a specialty and generic drug manufacturer that has been capturing attention with..
For investors seeking exposure to the burgeoning field of psychedelic therapeutics, COMPASS Pathways Plc (NASDAQ: CMPS) presents a compelling opportunity. As a healthcare company specializing in mental health innovations, COMPASS..
Organogenesis Holdings Inc. (NASDAQ: ORGO) presents an intriguing opportunity for investors seeking exposure to the healthcare sector, specifically within the niche of regenerative medicine. With a market capitalization of $474.65..
Eton Pharmaceuticals, Inc. (NASDAQ: ETON) is quickly becoming a notable player in the healthcare sector, specifically within the niche of specialty and generic drug manufacturing. This Deer Park, Illinois-based company..
Arbutus Biopharma Corporation (NASDAQ: ABUS), a clinical-stage biopharmaceutical company focusing on innovative treatments for infectious diseases, is capturing investor interest with its compelling potential upside of 43.96%. As the company..
Investors in the biotechnology sector may find CorMedix Inc. (NASDAQ: CRMD) to be an intriguing prospect, particularly given the impressive potential upside of 101.86% as highlighted by current analyst ratings...
Semler Scientific, Inc. (NASDAQ: SMLR), a U.S.-based company specializing in medical devices, is attracting significant investor attention due to its remarkable potential upside of 258.65%. Despite facing notable financial hurdles,..
Akebia Therapeutics, Inc. (NASDAQ: AKBA), a prominent player in the healthcare sector specializing in drug manufacturing for kidney diseases, presents a compelling investment opportunity with significant potential upside. With a..
Zenas BioPharma, Inc. (ZBIO), a burgeoning player in the biotechnology sector, is capturing investor attention with its promising pipeline of immunology-based therapies and a current analyst consensus pointing to a..
Investors with an eye on the burgeoning field of cancer diagnostics may want to consider Personalis, Inc. (NASDAQ: PSNL), a significant player in the healthcare sector’s diagnostics and research industry...
Sionna Therapeutics, Inc. (NASDAQ: SION), a key player in the biotechnology sector, has been making waves with its focus on innovative treatments for cystic fibrosis (CF). With a market capitalization..
Keros Therapeutics, Inc. (NASDAQ: KROS) is making waves in the biotechnology sector with its promising pipeline and recent analyst ratings suggesting a substantial growth potential. With a current market capitalization..
Stoke Therapeutics, Inc. (NASDAQ: STOK) is gaining attention in the biotechnology sector, not just for its innovative approach to treating severe genetic diseases but also for its promising stock performance..
Vir Biotechnology, Inc. (NASDAQ: VIR), a clinical-stage biopharmaceutical company, has captured investor attention with its potential for significant upside, despite facing formidable challenges in its current financial metrics. The company,..
